Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure.

A Caprani, A Richert, P Flaud

Journal: Bioelectromagnetics 2004;25(4):313-5

PMID: 15114641

Abstract

We have used the EaHy926 endothelial cell line, able to secrete both pro and anti-aggregant platelet agents, as a model for thrombo-embolic diseases. We experimentally established, by comparing these two secretions with or without a Faraday cage, that the environmental electromagnetic field significantly increases the thrombo-embolic risks in this endothelial cell line.

Address: LBHP, CNRS UMR 7057, Université Paris 7, Jussieu, Paris, France. [email protected]

DOI: 10.1002/bem.20022

Link outs

Free resources

Medical:

https://medlineplus.gov/electromagneticfields.html

Subscription / membership required

Full Text Sources:

https://doi.org/10.1002/bem.20022

MeSH Terms: 6-Ketoprostaglandin F1 alpha, Cell Line, Electromagnetic Fields, Endothelium, Vascular, Enzyme-Linked Immunosorbent Assay, Epoprostenol, Humans, Risk Factors, Thromboembolism, Thromboxane A2, Thromboxane B2